Navigation Links
Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100
Date:9/2/2010

PITTSBURGH, Sept. 2 /PRNewswire/ -- Precision Therapeutics ranked first place as an industry leader in the health care division and third place across all industries on the Pittsburgh Business Times Top 100 list, which identifies the area's fastest-growing, privately held companies.

With a growth rate of 847% since 2007, Precision has become an industry leader in personalized cancer therapy by recently hiring 100 new employees and raising $35 million in venture capital to provide additional support for expanding the distribution of the Company's core product, ChemoFx®.

"I believe this award belongs to each and every Precision employee.  It is with great pride that I extend my congratulations and gratitude for their tremendous skills and efforts in helping us to achieve this prestigious honor," says Sean McDonald, CEO of Precision Therapeutics.

About Precision Therapeutics

Precision Therapeutics, a life-science company based in Pittsburgh, Pennsylvania, is committed to improving outcomes of cancer patients. Known for their expertise in the science of individualizing cancer therapy through the use of a proprietary and unique live-tissue platform, Precision develops novel markers to help guide treatment decisions based on the biological processes of each individual's cancer.

Precision's state of the art bioinformatics combined with the analysis of the live molecular, proteomic and genomic activity of each patient's cancer offers an innovative foundation for further development and commercialization of novel predictive markers for cancer therapy.  For more information, please visit www.precisiontherapeutics.com.

About ChemoFx®

Precision's first commercial test, ChemoFx®, is a proprietary drug response marker which measures an individual's malignant tumor response to a range of standard therapeutic alternatives under consideration by a physician.  For more information, please visit www.chemofx.com.


'/>"/>
SOURCE Precision Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. 96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS
2. Applied Precision Announces New Products for Life Sciences Microscopy at the 110th American Society for Microbiology Meeting in San Diego, CA, May 23-26th.
3. Precision Bearing Technologies Featured at Atlantic Design & Manufacturing Show
4. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
5. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
6. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
7. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
8. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
9. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
10. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
11. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... company focused on tissue protection, repair and regeneration, ... Co., Ltd., received a positive response from the ... design for RGN-137 to treat epidermolysis bullosa ("EB"). ... incorporates Thymosin beta 4 ("Tß4") as the active ...
(Date:2/27/2017)... Leading Countries, Technologies and Companies The global ... CAGR of 8.9% from 2016-2021 and CAGR of 9.2% from 2021-2027. ... from 2016 to 2027. The market is estimated at $816m in ... ... to discover how you can exploit the future business opportunities emerging ...
(Date:2/27/2017)... Netherlands , Feb 27, 2017 ... is approved by NATO for use at the security level ... imposed within the NATO organization for the communication of classified ... ... government authorities with an eavesdrop-secure smartphone solution. Sectra Tiger/R is ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... ... Miro is the ultimate smart media center that offers a fascinating home ... and much more apps for user exploration. Its innovative acoustic design with premium speakers ... 720 provides crisp images with remarkable clarity and color. The WiFi connection enables its ...
(Date:2/27/2017)... ... 27, 2017 , ... Texas based retail electric company Discount ... RCE (Residential Customer Equivalent) count exceeds 150,000. , Discount Power was ... and 2,250 RCEs at the time of acquisition. In the three years since ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley ... to announce a new informational post on robotic hair transplantation. San Francisco residents ... hair transplant and Follicular Unit Transplantation (FUT) can sound similar. Either treatment can ...
(Date:2/27/2017)... ... , ... New Jersey ranks among the top five states in the entire ... for advanced services is growing. , Project WE vs C is a focused ... their non-profit partners in their fight against cancer and in support of their shared ...
(Date:2/26/2017)... ... February 26, 2017 , ... Today, A' Design Awards ... of International Social Design Awards. , The 7th A' Social Design Award ... and Institutions worldwide with realized projects and conceptual works. , The first phase ...
Breaking Medicine News(10 mins):